Topiramate is a sulfamate-substituted monosaccharide and is classified as an anticonvulsant. Its primary mechanism of action involves the inhibition of voltage-gated sodium channels, enhancement of gamma-aminobutyric acid (GABA) activity, antagonism of the AMPA/kainate subtype of the glutamate receptor, and inhibition of carbonic anhydrase. These mechanisms contribute to its effectiveness in managing seizure disorders and migraine prevention.
